TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/13/18 16:06 | 8/9/18 | RGEN | Repligen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Eddleman Roy T | CA | T | S | -5,761 | 49.63 | 0 | -116 | -3 | 3,631 | I | |||||||||||||||
8/8/18 18:10 | 8/6/18 | RGEN | Repligen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Eddleman Roy T | CA | T | S.m | -2,645 | 49.05 | 0 | -54 | -1 | 4,084 | M | |||||||||||||||
5/18/18 10:46 | 5/16/18 | RGEN | Repligen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Eddleman Roy T | CA | T | S | -5,000 | 42.07 | 0 | -119 | -3 | 4,543 | I | |||||||||||||||
5/10/18 16:32 | 5/8/18 | RGEN | Repligen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Eddleman Roy T | CA | T | S.am | -4,874 | 40.62 | 0 | -120 | -3 | 3,832 | I | |||||||||||||||
5/9/18 18:59 | 5/8/18 | RGEN | Repligen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Eddleman Roy T | CA | T | S.m | -4,874 | 40.62 | 0 | -120 | -3 | 4,252 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |